Introduction. Phospholipase A 2 (PLA 2 ) is a group of lipolytic enzymes that catalyze the hydrolysis of fatty acid ester bonds at the sn-2 position of phospholipids. This enzyme is thought to play an important role in the biosynthesis of eicosanoids via the release of arachidonic acid from biomembranes. Another product from biomembranes, a lysophospholipid, is converted to plateletactivating factor (PAF) known as an inflammatory mediator. PLA 2 s have been generally classified into secretory PLA 2 (sPLA 2 ), cytosolic PLA 2 (cPLA 2 ), and Ca 2+ -independent PLA 2 (iPLA 2 ) by their molecular weights, amino acid sequences, and calcium requirements. 1 cPLA 2 comprises three distinct types of enzymes: R, β, and γ. 2 cPLA 2 R, an 85-kDa protein, contains a calcium-dependent lipid binding domain and a catalytic domain, requires micromolar levels of Ca 2+ for membrane translocation, and has a specificity for arachidonic acid bound to the sn-2 position of phospholipids 3 in contrast with sPLA 2 and iPLA 2 which have broad substrate specificities, suggesting that cPLA 2 R is involved in the production of eicosanoids.

No abstract

Monopolar spindle 1 (Mps1) is an attractive oncology target due to its high expression level in cancer cells as well as the correlation of its expression levels with histological grades of cancers. An imidazo[1,2-a]pyrazine 10a was identified during an HTS campaign. Although 10a exhibited good biochemical activity, its moderate cellular as well as antiproliferative activities needed to be improved. The cocrystal structure of an analogue of 10a guided our lead optimization to introduce substituents at the 6-position of the scaffold, giving the 6-aryl substituted 21b which had improved cellular activity but no oral bioavailability in rat. Property-based optimization at the 6-position and a scaffold change led to the discovery of the imidazo[1,2-b]pyridazine-based 27f, an extremely potent (cellular Mps1 IC50 = 0.70 nM, A549 IC50 = 6.0 nM), selective Mps1 inhibitor over 192 kinases, which could be orally administered and was active in vivo. This 27f demonstrated remarkable antiproliferative activity in the nanomolar range against various tissue cancer cell lines.

Penicillium digitatum spores were inactivated using an oxygen-radical source that supplies only neutral oxygen radicals. Vacuum ultraviolet absorption spectroscopy was used to measure the ground-state atomic oxygen [O (3Pj)] densities and they were estimated to be in the range of 1014–1015 cm-3. The inactivation rate of P. digitatum spores was correlated with the O (3Pj) density. The result indicates that O (3Pj) is the dominant species in the inactivation. The inactivation rate constant of P. digitatum spores by O (3Pj) was estimated to be on the order of 10-17 cm3 s-1 from the measured O (3Pj) densities and inactivation rates.

The effectiveness of atomic and excited molecular oxygen species at inactivating Penicillium digitatum spores was quantitatively investigated by measuring these species and evaluating the spore inactivation rate. To avoid the effects of ultraviolet light and charged species, a non-equilibrium atmospheric-pressure radical source, which supplies only neutral radicals, was employed. Ground-state atomic oxygen (O(3Pj)) and excited molecular oxygen (O2(1Δg)) species were measured using vacuum ultraviolet absorption spectroscopy. The inactivation rate of spores was evaluated using the colony count method. The lifetimes of O(3Pj) and O2(1Δg) in an argon gas ambient at atmospheric pressure were found to be about 0.5 ms and much more than tens of ms, and their spore inactivation rates were about 10−17 cm3 s−1 and much lower than 10−21 cm3 s−1, respectively.